NCT00979836

Brief Summary

The objective of the study is to assess the efficacy of calcium dobesilate for treating chronic venous wounds. The hypothesis is that venous ulcers treated with standards measures (compressive measures) and calcium dobesilate will heal-up better than venous ulcers treated with standards measures (compressive measures) and placebo.

Trial Health

40
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
230

participants targeted

Target at P25-P50 for phase_3

Geographic Reach
1 country

42 active sites

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

September 17, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 18, 2009

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Last Updated

February 17, 2011

Status Verified

February 1, 2011

Enrollment Period

2.2 years

First QC Date

September 17, 2009

Last Update Submit

February 16, 2011

Conditions

Keywords

venousulcerphlebotoniccalcium dobesilateclinical trial

Outcome Measures

Primary Outcomes (1)

  • Healed venous ulcers

    at 6 months of treatment

Secondary Outcomes (5)

  • Percentage of re-epithelization area (cm2)

    at 6 month of treatment

  • Length of time to heal ulcers

    during all the period of the study (12 months)

  • Ulcer recurrence

    at 12 month

  • Ulcer pain

    at 6 and 12 months

  • Safety

    during the study (12 months)

Study Arms (2)

Calcium Dobesilate

EXPERIMENTAL
Drug: Calcium Dobesilate

Placebo

PLACEBO COMPARATOR

The placebo is a capsule with the same presence of experimental drug.

Drug: Calcium Dobesilate

Interventions

500 mg/ three times/day for 6 months (capsules)

Also known as: Doxium
Calcium DobesilatePlacebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with venous ulcer (CEAP 6) that affect epidermis, dermis and/or subcutaneous tissue, with and area superior to 3 cm2
  • Ankle-arm index 0.9 or superior
  • Written informed consent of the patients

You may not qualify if:

  • Patients with venous ulcer (CEAP 6) that affect bone or with and area inferior to 3 cm2
  • Ankle-arm index inferior to 0.9
  • No written informed consent of the patients
  • Diabetes mellitus I y II
  • Patients with renal failure and dialysis
  • Vascular surgery needed
  • Impossibility to use compressive measures on the leg
  • Use of topic antibiotics, silver dressing, growth factors, plasma-rich in platelets, skin graft, pentoxifylline, ultrasounds, laser, hyperbaric oxygen, electric stimulation o vacuum.
  • Pregnancy
  • Breast feeding
  • No anticonceptives measures
  • Allergy or intolerance to phebotonics
  • Background of neutropenia or leucopenia
  • Basal leucocytes \< 3.500/ml

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (42)

Hospital General de Albacete

Albacete, Albacete, 02006, Spain

Location

Hospital Germans Tries i Pujol

Badalona, Barcelona, 08916, Spain

Location

CAP Joanic

Barcelona, Barcelona, 08025, Spain

Location

Hospital Sant Jaume de Calella

Calella, Barcelona, 08370, Spain

Location

CAP El Castell

Castelldefels, Barcelona, 08660, Spain

Location

Hospital General de Granollers

Granollers, Barcelona, 08402, Spain

Location

Consorci Hospitalari de Mataró

Mataró, Barcelona, 08304, Spain

Location

CAP Pineda de Mar

Pineda de Mar, Barcelona, 08397, Spain

Location

Corpotació Sanitària Parc Taulí

Sabadell, Barcelona, 08208, Spain

Location

CAP Sitges

Sitges, Barcelona, 08870, Spain

Location

CAP El Remei

Vic, Barcelona, 08500, Spain

Location

Hospital de Vic

Vic, Barcelona, 08500, Spain

Location

CAP Doctor Guillermo Masriera i Guardiola

Vilassar de Mar, Barcelona, 08340, Spain

Location

CAP Les Corts

Barcelona, Catalonia, 08015, Spain

Location

CAP Gaudí

Barcelona, Catalonia, 08025, Spain

Location

CAP Sagrada Familia

Barcelona, Catalonia, 08025, Spain

Location

CAP Vila de Gràcia

Barcelona, Catalonia, 08025, Spain

Location

EAP Sardenya

Barcelona, Catalonia, 08025, Spain

Location

Hospital de la Santa Creu i Sant Pau

Barcelona, Catalonia, 08025, Spain

Location

Hospital Dos de Maig

Barcelona, Catalonia, 08025, Spain

Location

CAP la Sagrera

Barcelona, Catalonia, 08027, Spain

Location

CAPSE

Barcelona, Catalonia, 08036, Spain

Location

ABS Encants

Barcelona, Catalonia, 08041, Spain

Location

ABS Lesseps

Barcelona, Catalonia, 902011040, Spain

Location

CAP la Salut

Barcelona, Catalonia, 902011040, Spain

Location

CAP Barceloneta

Barcelona, Catalonia, Spain

Location

CAP Vila Olímpica

Barcelona, Catalonia, Spain

Location

CAP Albera Salut

Peralada, Girona, 17491, Spain

Location

Hospital de Leon

León, Leon, 24071, Spain

Location

Fundación Hospital de Alcorcón

Alcorcón, Madrid, 28922, Spain

Location

Hospital de Getafe

Getafe, Madrid, 28905, Spain

Location

Complejo Hospitalario de Son Dureta

Mallorca, Mallorca, 07014, Spain

Location

Hospital de Cabueñes

Gijón, Principality of Asturias, 33394, Spain

Location

Hospital Central de Asturias

Oviedo, Principality of Asturias, 33006, Spain

Location

Hospital Sant Joan de Reus

Reus, Tarragona, 43201, Spain

Location

CAP Vila-Rodona

Vilarrodona, Tarragona, 43814, Spain

Location

Hospital Clínico Universitario de Valladolid

Valladolid, Valladolid, 47005, Spain

Location

Hospital Platon

Barcelona, Spain

Location

Hospital Virgen de las Nieves

Granada, 18014, Spain

Location

Hospital San Pedro de Logroño

Logroño, 26006, Spain

Location

Hospital la Princesa

Madrid, 28005, Spain

Location

Hospital Clínico Universitario San Carlos

Madrid, 28905, Spain

Location

Related Publications (1)

  • Martinez-Zapata MJ, Vernooij RW, Simancas-Racines D, Uriona Tuma SM, Stein AT, Moreno Carriles RMM, Vargas E, Bonfill Cosp X. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev. 2020 Nov 3;11(11):CD003229. doi: 10.1002/14651858.CD003229.pub4.

MeSH Terms

Conditions

Ulcer

Interventions

Calcium Dobesilate

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BenzenesulfonatesBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsArylsulfonatesArylsulfonic AcidsSulfonic AcidsSulfur AcidsSulfur Compounds

Study Officials

  • Moreno Carriles, Rosa Mª

    Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 17, 2009

First Posted

September 18, 2009

Study Start

April 1, 2008

Primary Completion

July 1, 2010

Last Updated

February 17, 2011

Record last verified: 2011-02

Locations